Key terms

About LBPH

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest LBPH news

Apr 16 6:26am ET Bexicaserin’s Promising Future: Buy Rating Justified by Strong Clinical Data and Potential Blockbuster Status Apr 16 6:00am ET Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Laboratory (LH) and Longboard Pharmaceuticals (LBPH) Apr 15 9:32am ET Longboard Pharmaceuticals to Reveal Bexicaserin Study Results Mar 15 10:30am ET Analysts’ Top Healthcare Picks: Longboard Pharmaceuticals (LBPH), Phathom Pharmaceuticals (PHAT) Mar 14 2:03am ET Longboard Pharmaceuticals Embarks on Risky Global Expansion Amid Regulatory Hurdles and Market Instability Mar 13 5:46am ET Buy Rating Affirmed: Longboard Pharmaceuticals’ Bexicaserin Shows Promising Efficacy and Strategic Milestones Mar 12 4:47pm ET Longboard Pharmaceuticals files automatic mixed securities shelf Mar 12 4:22pm ET Longboard Pharmaceuticals Shares Key Corporate Presentation Mar 12 4:03pm ET Longboard Pharmaceuticals reports FY23 EPS ($2.39), consensus ($2.40) Feb 16 2:18pm ET Longboard Pharmaceuticals Inc trading resumes Feb 16 2:08pm ET Longboard Pharmaceuticals Inc trading halted, volatility trading pause Feb 15 4:10pm ET Longboard Pharmaceuticals initiated with a Buy at Citi Jan 26 8:55am ET Longboard Pharmaceuticals 4M share Block Trade priced at $24.25 Jan 18 8:30am ET Two new option listings and one option delisting on January 18th

No recent press releases are available for LBPH

LBPH Financials

1-year income & revenue

Key terms

LBPH Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

LBPH Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms